SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,382.47 472.77
( 0.66%)

Global Indices

Nasdaq

51,190.24 242.68
(0.48%)

Dow Jones

7,742.36 54.91
(0.71%)

Hang Seng

69,916.07 1,606.61
(2.35%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

96.17 0.25
(0.26%)

EUR-INR

108.49 -0.30
(-0.28%)

GBP-INR

127.16 -0.03
(-0.02%)

JPY-INR

0.61 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.604918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

44.84

86.16

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

spacenet enterprises india ltd

Titan Biotech consolidated net profit rises 58.31% in the June 2026 quarter

Aug 14,2026

Net profit of Titan Biotech rose 58.31% to Rs 10.86 crore in the quarter ended June 2026 as against Rs 6.86 crore during the previous quarter ended June 2025. Sales rose 27.25% to Rs 59.17 crore in the quarter ended June 2026 as against Rs 46.50 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	59.17	46.50	27
OPM %	21.11	18.80	-
PBDT	14.10	9.26	52
PBT	12.73	8.11	57
NP	10.86	6.86	58

72,382.47 472.77 ( 0.66%)

51,190.24 242.68 (0.48%)

7,742.36 54.91 (0.71%)

69,916.07 1,606.61 (2.35%)

10,455.36 27.09 (0.26%)

96.17 0.25 (0.26%)

108.49 -0.30 (-0.28%)

127.16 -0.03 (-0.02%)

0.61 0.00 (-0.36%)